Detection of DNA damage in circulating tumour cells harvested from blood samples of ovarian and prostate cancer patients | Read More
Integrating isolation using label-independent microfluidics and advanced staining for comprehensive Circulating Tumour Cell Analysis | Read More
Leptomeningeal disease in HER2+ demonstrates a remarkable clinical response to systemic and intrathecal trastuzumab, demonstrating therapeutic value | Read More
Blood-Based Biomarker Analysis for Predicting Efficacy of Chemoradiotherapy and Durvalumab in Patients with Unresectable Stage III Non-Small Cell Lung Cancer | Read More
Epithelial and mesenchymal CTC detection in triple negative breast cancer patients using ANGLE’s Parsortix® system | Read More
Clinical significance of circulating tumor cells after chemotherapy in unresectable pancreatic ductal adenocarcinoma | Read More
Blood-based biomarker analysis for predicting efficacy of definitive concurrent chemoradiotherapy and durvalumab consolidation in patients with unresectable locally advanced non-small cell lung cancer | Read More
Diagnostic and Prognostic Value of Cell-Surface Vimentin-Positive Circulating Tumor Cells in Pediatric Sarcoma Patients | Read More
Application of circulating genetically abnormal cells in the diagnosis of early-stage lung cancer | Read More
Monitoring levels of vimentin-positive circulating cancer stem cells and tumor cells in patients with advanced EGFR-mutated non-small cell lung cancer | Read More
Utilization of BioView’s automated imaging and analysis technology in combination with ANGLE plc PARSORTIX system for investigation of PD-L1 expression in circulating tumor cells isolated using the Parsortix system in metastatic lung and breast cancer patients| Read More
Utilization of BioView’s automated imaging and analysis technology in combination with ANGLE plc PARSORTIX system and its new epithelial-to-mesenchymal transition (EMT) assay to isolate and identify both epithelial and mesenchymal circulating tumor cells (CTCs) in 47 metastatic breast cancer (MBC) and 48 non-small cell lung cancer (NSCLC) patients| Read More
Circulating tumour cells as an indicator of early and systemic recurrence after surgical resection in pancreatic ductal adenocarcinoma | Read More
Detection of circulating genetically abnormal cells in peripheral blood for early diagnosis of non‐small cell lung cancer | Read More
Detection of circulating genetically abnormal cells using 4-color fluorescence in situ hybridization for the early detection of lung cancer | Read More
Innovative CTC FISH test for early diagnosis of lung cancer | Read More
Identification of circulating tumor cells using 4‐color fluorescence in situ hybridization: Validation of a noninvasive aid for ruling out lung cancer in patients with low‐dose computed tomography–detected lung nodules| Read More
Circulating Tumor Cells Enumerated by a Centrifugal Microfluidic Device as a Predictive Marker for Monitoring Ovarian Cancer Treatment: A Pilot Study | Read More
Evaluation of the diagnostic value of circulating tumor cells with CytoSorter® CTC capture system in patients with breast cancer | Read More
Combinatory Analysis of Cell-free and Circulating Tumor Cell DNAs Provides More Variants for Cancer Treatment | Read More
Mutant-p53 antibody stains cytokeratin negative CTCs enriched and detected with a “Pan-CTC” antibody cocktail | Read More
Evaluation of therapeutic efficacy with CytoSorter® circulating tumor cell–capture system in patients with locally advanced head and neck squamous cell carcinoma | Read More
HER-2 status of circulating tumor cells in a metastatic breast cancer cohort: A comparative study on characterization techniques| Read More
Toward Microfluidic Label‐Free Isolation and Enumeration of Circulating Tumor Cells from Blood Samples | Read More
Urovysion FISH Could Be Effective and Useful Method to Confirm the Identity of Cultured Circulating Tumor Cells from Bladder Cancer Patient | Read More
BioView integrated all-in-one imaging system with artificial intelligence (AI) solution for the identification of circulating tumor cells and circulating fetal cells | Read More
VTX-1 Liquid Biopsy System for Fully-Automated and Label-Free Isolation of Circulating Tumor Cells with Automated Enumeration by BioView Platform | Read More
Detection and Analysis of Circulating Epithelial Cells in Liquid Biopsies From Patients With Liver Disease | Read More
Relationship between hepatocellular carcinoma circulating tumor cells and tumor volume | Read More
Personalized genomic analysis based on circulating tumor cells of extra‑skeletal Ewing sarcoma of the uterus: A case report of a 16‑year‑old Korean female| Read More
A study of PD-L1 expression in KRAS mutant non-small cell lung cancer cell lines exposed to relevant targeted treatments | Read More
Isolation of Circulating Plasma Cells in Multiple Myeloma Using CD138 Antibody-Based Capture in a Microfluidic Device | Read More
Expression of β-globin by cancer cells promotes cell survival during blood-borne dissemination | Read More
HER2 expression identifies dynamic functional states within circulating breast cancer cells | Read More
Characterization of PD-L1 expression on circulating tumor cells (CTCs) isolated with a label-free inertial microfluidic system from advanced non-small cell lung cancer patients (NSCLC pts)| Read More
Inertial Focusing for Tumor Antigen Dependent and Independent Sorting of Rare Circulating Tumor Cells | Read More
Supplemental Discussion: The Herringbone HBCTC-Chip used as a technology to enrich for CTCs from epithelial cancers | Read More
A prospective evaluation of circulating tumor cells and cell-free DNA in EGFR mutant non-small cell lung cancer patients treated with erlotinib on a phase II trial| Read More
Immunohistochemistry in the Study of Cancer Biomarkers for Oncology Drug Development | Read More
Tunable Nanostructured Coating for the Capture and Selective Release of Viable Circulating Tumor Cells | Read More
Bioengineered implantable scaffolds as a tool to study stromal-derived factors in metastatic cancer models | Read More
A microfluidic device for label-free, physical capture of circulating tumor cell clusters | Read More
The Identification and Characterization of Breast Cancer CTCs Competent for Brain Metastasis | Read More
MAPK7 regulates EMT Features and Modulates the Generation of CTCs | Read More
Optimisation of an immunohistochemistry method for the determination of androgen receptor expression levels in circulating tumour cells | Read More
Circulating Tumor Cells: A Multifunctional Biomarker | Read More
Androgen Receptor Signaling in Circulating Tumor Cells as a Marker of Hormonally Responsive Prostate Cancer | Read More
Genetically Abnormal Circulating Cells in Lung Cancer Patients: An Antigen-Independent Fluorescence In situ Hybridization–Based Case-Control Study | Read More
Circulating Tumor Cells Are Transcriptionally Similar to the Primary Tumor in a Murine Prostate Model | Read More
Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches | Read More
A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker | Read More
Pathology:
ETV6 Molecular Heterogeneity in Salivary Secretory Carcinoma: A Case Series Report and Literature Review | Read More
Development of CDK4/6 inhibitor resistant ER-positive HER2-negative breast cancer cell lines to elucidate novel mechanisms of resistance | Read More
MET receptor serves as a promising target in melanoma brain metastases | Read More
High HER2 intratumoral heterogeneity is a predictive factor for poor prognosis in Early-stage and Locally Advanced HER2-positive Breast Cancer | Read More
Comprehensive analysis of clonality, segregation errors, CIN, and heterogeneity reveals that cancer evolution is often promoted by highly aberrant cellular divisions | Read More
The LungLB™ test identifies circulating genetically abnormal cells that have been shown to be present early in lung cancer pathogenesis| Read More
Multiplex interphase miFISH hybridization technique to study Single-cell resolved ploidy and chromosomal aberrations in nonalcoholic steatohepatitis-(NASH) induced hepatocellular carcinoma and its precursor lesions | Read More
Ovarian adenomatoid tumor sections hybridized with the CDKN2A/p16 probe | Read More
USP6-associated neoplasm as a tentative subset of postoperative spindle cell nodule | Read More
BioView System Validation in Pathology Laboratory | Read More
Correlation of ROS1 (D4D6) Immunohistochemistry with ROS1 Fluorescence In Situ Hybridization Assay in a Contemporary Cohort of Pulmonary Adenocarcinomas | Read More
ALK Translocation in ALK-Positive Mesenchymal Tumors | Read More
CD24 is a surrogate for ‘immune-cold’ phenotype in aggressive large B-cell lymphoma | Read More
Assessment of ALK Fusions in Uncommon Inflammatory Myofibroblastic Tumors With ALK IHC Positivity but FISH-Equivocal Findings by Targeted RNA Sequencing | Read More
MA14.02 RET Fusion Testing in Advanced Non-Small Cell Lung Carcinoma Patients: the RETING Study | Read More
Detection of Endogenous DNA Double-strand Breaks in Oral Squamous Epithelial Lesions by P53-binding Protein 1 | Read More
9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavorable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trial | Read More
Comparison of PD-L1, EGFR, ALK, and ROS1 Status Between Surgical Samples and Cytological Samples in Non-Small Cell Lung Carcinoma | Read More
Immunohistochemical staining patterns of p53 predict the mutational status of TP53 in oral epithelial dysplasia | Read More
Mixed Neuroendocrine/Non‑neuroendocrine Neoplasm (MiNEN) of the Ovary Arising from Endometriosis: Molecular Pathology Analysis in Support of a Pathogenetic Paradigm | Read More
FISH analysis of brain smears obtained at intraoperative diagnosis – An accurate and fast method to detect 1p/19q-codeletion in gliomas| Read More
Analytical Accuracy of RET Fusion Detection by Break-Apart Fluorescence In Situ Hybridization | Read More
Reappraisal of HER2 Amplification in High-Grade Urothelial Carcinoma Based on 2018 ASCO/CAP Clinical Practice Guidelines | Read More
CAPP‑seq analysis of circulating tumor DNA from patients with EGFR T790M–positive lung cancer after osimertinib | Read More
Concordance of the 21-gene assay between core needle biopsy and resection specimens in early breast cancer patients | Read More
Clinical and Genomic Characteristics of Adult Diffuse Midline Glioma| Read More
CDKL2 Is Associated with HER2 Status and Overall Survival in Gastric Cancer: Comparative Analysis of CDKL2 Protein Expression and Gene Copy Number | Read More
High prevalence of ROS1 gene rearrangement detected by FISH in EGFR and ALK negative lung adenocarcinoma | Read More
Malignant transformation and genetic alterations are uncoupled in early colorectal cancer progression| Read More
Analysis of primary central nervous system large B-cell lymphoma in the era of high-grade B-cell lymphoma: Detection of two cases with MYC and BCL6 rearrangements in a cohort of 12 cases | Read More
Multiplex fast FISH assay for detecting ROS1, RET and MET aberrations in FFPE specimens using BioView image analysis – Abstract | Read More
Evaluation of NR4A3 immunohistochemistry (IHC) and fluorescence in situ hybridization and comparison with DOG1 IHC for FNA diagnosis of acinic cell carcinoma | Read More
High level MYCN amplification and distinct methylation signature define an aggressive subtype of spinal cord ependymoma | Read More
AACR 2020 Poster: Multiplex fast FISH assay for detecting ROS1, RET and MET aberrations in FFPE specimens using BioView image analysis | Read More
An Integrative Genetic, Epigenetic and Proteomic Characterization of Pancreatic Neuroendocrine Neoplasms (PanNENs) defines Distinct Molecular Features of α- and β-cell like Subgroups | Read More
Composite follicular lymphoma and “early” (in situ and mantle zone growth pattern) mantle cell neoplasia: A rare entity with peculiar cytogenetic and clinical features | Read More
Advances in tissue-based imaging: impact on oncology research and clinical practice | Read More
Automation of ALK gene rearrangement testing with fluorescence in situ hybridization (FISH): A feasibility study| Read More
High levels of chromosomal copy number alterations and TP53 mutations correlate with poor outcome in younger breast cancer patients | Read More
International Harmonization of Provisional Diagnostic Criteria for ERBB2-Amplified Metastatic Colorectal Cancer Allowing for Screening by Next-Generation Sequencing Panel| Read More
Patterns and genomic correlates of PD-L1 expression in patients with biliary tract cancers| Read More
Genomic profiling of primary histiocytic sarcoma reveals two molecular subgroups | Read More
Diagnosis of uncommon renal epithelial neoplasms: performances of fluorescence in situ hybridization | Read More
High Incidence of MYC Rearrangement in HIV‐Positive Plasmablastic Lymphoma | Read More
Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Non-Small Cell Lung Carcinoma Patients: the ROSING Study| Read More
Accurate Estrogen Receptor Quantification in Patients with Negative and Low-Positive Estrogen-ReceptorExpressing Breast Tumors: Sub-Analyses of Data from Two Clinical Studies | Read More
Non-invasive early detection of malignant pulmonary nodules by FISH-based sputum test | Read More
Single‐cell genetic analysis of clonal dynamics in colorectal adenomas indicates CDX2 gain as a predictor of recurrence | Read More
Reviving oncogenic addiction to MET bypassed by BRAF (G469A) mutation | Read More
Optimization of routine testing for MET exon 14 splice site mutations in non-small cell lung cancer patients | Read More
ALK Rearrangements Are Infrequent in Cellular Blue Nevus and Deep Penetrating Nevus | Read More
Non-Invasive Early Detection of Malignant Pulmonary Nodules by FISH-Based Sputum Test | Read More
Aneuploidy, TP53 mutation, and amplification of MYC correlate with increased intratumor heterogeneity and poor prognosis of breast cancer patients | Read More
Fluorescence In Situ Hybridization (FISH) Analysis of a Series of 47 Lymphomas using the BioView System | Read More
Characterization of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program | Read More
Validation of ALK/ROS1 Dual Break Apart FISH Probe probe in Non-small-cell lung cancer | Read More
Clinical Utility of Chromosomal Aneusomy in Individuals at High Risk of Lung Cancer| Read More
ROS1 Gene Fusion in Advanced Lung Cancer in Women: A Systematic Analysis, Review of the Literature, and Diagnostic Algorithm | Read More
ALK Testing in Lung Adenocarcinoma. Technical Aspects to Improve FISH Evaluation in Daily Practice| Read More
Breast Cancer Biomarkers Before and After Neoadjuvant Chemotherapy: Does Repeat Testing Impact Therapeutic Management? | Read More
Vulvar and vaginal melanoma: A unique subclass of mucosal melanoma based on a comprehensive molecular analysis of 51 cases compared with 2253 cases of nongynecologic melanoma | Read More
Utilization of Innovative Web Based FISH Review and Analysis Solution in Daily Clinical Practice | Read More
Testing for ROS1 in non-small cell lung cancer: a review with recommendations | Read More
Precision medicine in NSCLC and pathology: how does ALK fit in the pathway? | Read More
Genomic alterations in neuroendocrine cancers of the ovary | Read More
Genomic landscape of small cell carcinoma of the breast contrasted to small cell carcinoma of the lung | Read More
Clinical Significance of “Double-hit” and “Double-protein” expression in Primary Gastric B-cell Lymphomas | Read More
Profile of Ventana ALK (D5F3) companion diagnostic assay for non-small-cell lung carcinomas | Read More
Definition of MYC genetic heteroclonality in diffuse large B-cell lymphoma with 8q24 rearrangement and its impact on protein expression | Read More
ALK Protein Analysis by IHC Staining after Recent Regulatory Changes: A Comparison of Two Widely Used Approaches, Revision of the Literature, and a New Testing Algorithm | Read More
Materials and methods for assessing progression of prostate cancer | Read More
Molecular profiling of head and neck squamous cell carcinoma | Read More
The anaplastic lymphoma kinase testing Conundrum |Read More
ALK testing in lung adenocarcinoma: technical aspects to improve FISH evaluation indaily practice | Read More
Accurate Identification of ALK Positive Lung Carcinoma Patients: Novel FDA-Cleared Automated Fluorescence In Situ Hybridization Scanning System and Ultrasensitive Immunohistochemistry |Read More
Computerized Analysis of Cytology and Fluorescence In Situ Hybridization (FISH) in Induced Sputum for Lung Cancer Detection | Read More
Automation of ALK gene rearrangement testing with fluorescence in situ hybridization (FISH): a feasibility study | Read More
The t(14;18)(q32;q21)/IGH–MALT1 translocation in gastrointestinal extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) | Read More
Tumor derived vasculogenesis in von Hippel-Lindau disease-associated tumors | Read More
Oral lichen planus patients exhibit consistent chromosomal numerical aberrations: A follow-up analysis | Read More
Expression of human epidermal growth factor receptor 2 in primary and paired parenchymal recurrent and/or metastatic sites of gastric cancer | Read More
CDK4 amplification reduces sensitivity to CDK4/6 inhibition in fusion-positive rhabdomyosarcoma | Read More
Sequential phenotype/genotype FISH assay targeting rare tumor cells using archived bone marrow smears and paraffin embedded tissue sections | Read More
Human Barrett’s Adenocarcinoma of the Esophagus, Associated Myofibroblasts, and Endothelium Can Arise from Bone Marrow-Derived Cells After Allogeneic Stem Cell Transplant | Read More
Cytology Specimens Offer an Effective Alternative to Formalin-Fixed Tissue as Demonstrated by Novel Automated Detection for ALK Break-Apart FISH Testing and Immunohistochemistry in Lung Adenocarcinoma | Read More
ERG expression in epithelioid sarcoma: a diagnostic pitfall | Read More
Accurate assessment of HER2 status in “triple-negative” breast cancer requires both IHC and FISH testing | Read More
Cholangiocarcinoma in a 17-year-old boy with primary sclerosing cholangitis and UroVysion™ fluorescent in situ hybridization | Read More
Identification by array comparative genomic hybridization of a new amplicon on chromosome17q highly recurrent in BRCA1 mutated triple negative breast cancer | Read More
Bioview Duet – Assisted Fluorescence In Situ Hybridization for Gastrointestinal Malignancy | Read More
Molecular Pathology , a practical guide for the surgical pathologist and cytopathologist | Read More
Chromosomal numerical aberrations in apparently normal oral mucosa of heavy smokers affected by lung cancer | Read More
Noninvasive detection of aneuploid cells in laryngeal epithelial precursor lesions | Read More
Oral lichen planus patients exhibit consistent chromosomal numerical aberrations: A follow-up analysis | Read More
Bladder
Reappraisal of HER2 Amplification in High-Grade Urothelial Carcinoma Based on 2018 ASCO/CAP Clinical Practice Guidelines | Read More
“Indeterminate” UroVysion Fluorescence In Situ Hybridization Results: Clinical Implications of Diagnostic Terminology| Read More
Urovysion FISH Could Be Effective and Useful Method to Confirm the Identity of Cultured Circulating Tumor Cells from Bladder Cancer Patient | Read More
Role of Tetrasomy for the Diagnosis of Urothelial Carcinoma Using UroVysion Fluorescent In Situ Hybridization | Read More
A retrospective review of UroVysion fish interpretations over 8.6 years: a major shift in the patient test population |Read More
Integrating a FISH imaging system into the cytology laboratory | Read More
Validation and Clinical Utility Assessment of an Automated Capture/Analysis System for FISH to Detect Urothelial Carcinoma | Read More
Target UroVysion FISH for Urinary Specimens Using FISH for Urinary Specimens Using the Duet the Duet Imaging System | Read More
Guidelines for Pancreaticobiliary Cytology from the Papanicolaou Society of Cytopathology: A Review | Read More
‘‘FISHing’’ to Detect Urinary and Other Cancers | Read More
FISHING to detect urinary and other cancers: do imaging systems help? | Read More
Combined analysis of morphology and fluorescence in situ hybridization significantly increases accuracy of bladder cancer detection in voided urine samples | Read More
Target FISH
Single-cell profiling of multiple myeloma reveals molecular response to FGFR3 inhibitor despite clinical progression | Read More
FISH diagnostics in plasma cell myeloma: recommendations and our own experience | Read More
Multiple Myeloma Presenting in Patients Younger than 50 Years of Age: A Single Institution Experience| Read More
IgA plasma cell neoplasms are characterized by poorer long-term survival and increased genomic complexity compared to IgG neoplasms | Read More
Newly‐diagnosed multiple myeloma patients carrying monoallelic deletion of the whole locus of immunoglobulin heavy chain gene have a better prognosis compared to those with t(4;14) and t(14;16) | Read More
Non-invasive early detection of malignant pulmonary nodules by FISH-based sputum test | Read More
Target fluorescence in-situ hybridization (Target FISH) for plasma cell enrichment in myeloma | Read More
Characterizing T Cells in SCID Patients Presenting with Reactive or Residual T Lymphocytes | Read More
Multilineage hematopoietic engraftment after allogeneic peripheral blood stem cell transplantation without conditioning in SCID patients |Read More
Co-existence of clonal expanded autologous and transplacental-acquired maternal T cells in recombination activating gene-deficient severe combined immunodeficiency |Read More
Characterization of bone marrow mast cells in acute myeloid leukemia with t(8;21) (q22;q22); RUNX1-RUNX1T1 |Read More
MUC1 Is a Potential Target for the Treatment of Acute Myeloid Leukemia Stem Cells | Read More
Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease: clinical significance and comparison of chomosomal abnormalities in SM and AHNMD components | Read More
Trisomy 8 in B-cell chronic lymphocytic leukemia | Read More
Neoplastic mast cells in systemic mastocytosis associated with t(8;21) acute myeloid leukemia are derived from the leukemic clone |Read More
Fibroblast growth factor receptor 3 inhibition by short hairpin RNAs leads to apoptosis in multiple myeloma | Read More
Megakaryocytic blast crisis as a presenting manifestation of chronic myeloid leukemia | Read More
Targeting plasma cells improves detection of cytogenetic aberrations in multiple myeloma: phenotype/genotype fluorescence in situ hybridization | Read More
Morphology assessment and fluorescence in situ hybridization of the same spermatozoon using a computerized cell-scanning system |Read More
Ploidy of spermatogenic cells of men with non-mosaic Klinefelter’s syndrome as measured by a computerized cell scanning system | Read More
Combined analysis of morphology and fluorescence in situ hybridization in follow-up of minimal residual disease in a child with Philadelphia-positive acute lymphoblastic leukemia | Read More
Chimerism testing and detection of minimal residual disease after allogeneic hematopoietic transplantation using the BioView (Duet) combined morphological and cytogenetical analysis | Read More
Tetraploid myeloid cells in donors of peripheral blood stem cells treated with rhG-CSF | Read More
The multiparametric scanning system for evaluation of minimal residual disease in hematological malignancies | Read More
Determination of chromosome 13 status in bone marrow cells of patients with multiple myeloma using combined morphologic and fluorescence in situ hybridization analysis | Read More
Co-existence of multiple subclones in TEL-AML1 at diagnosis of acute lymphoblastic leukaemia in association with submicroscopic deletion of AML1 | Read More
Philadelphia-chromosome-positive T-lymphoblastic leukemia: acute leukemia or chronic myelogenous leukemia blastic crisis | Read More
Clonal expansion of a new MLL rearrangement in the absence of leukemia | Read More
Acquisition of a Ph chromosome with minor BCR/ABL fusion in treatment-related myelodysplastic syndrome with chromosome 7 abnormalities in a patient treated for Hodgkin disease | Read More
Detection of non-diploid cells in premalignant and malignant oral lesions using combined morphological and FISH analysis – a new method for early detection of suspicious oral lesions | Read More
Chromosome 13q deletion and IgH abnormalities may be both masked by near-tetraploidy in a high proportion of multiple myeloma patients: a combined morphology and I-FISH analysis | Read More
Could rhG-CSF induction of tetraploidy contribute to leukemogenesis in healthy donors? | Read More
Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient | Read More
Post-essential thrombocythemia myelofibrosis and chronic myelomonocytic leukemia can co-exist with complex cytogenetic abnormalities | Read More
Correlation between losses of IGH or its segments and deletions of 13q14 in t(11;14) (q13;q32) multiple myeloma | Read More
Combined simultaneous analysis of morphology and fluorescence in situ hybridization as a novel sensitive method for detecting small populations of malignant cells in patients with a high risk of cancer, premalignant lesions and minimal residual disease | Read More
Others:
BioView testimonial- Cytogenetic laboratory at Sheba Hospital | Read More
Rare CML chromosome variant responded well to Imatinib, suggesting the variant may not affect treatment success| Read More
BioView testimonial- HSL advanced diagnostics | Read More
High concordance with manual FISH analysis of CLL FISH panels. reduced hands-on use of microscopy, simplifying test review and analysis| Read More
Reduced hands-on use of microscopy, simplifying test review and analysis| Read More
New approach for interpretation of FFEP break apart fluorescence in-situ hybridization cases impacted by cell size and ploidy | Read More
High concordance with manual FISH analysis of CLL FISH panels. reduced hands-on use of microscopy, simplifying test review and analysis| Read More
Potential Prognostic Significance of Patterns of Deletion (13q) in Plasma Cell Myelomas—Reappraisal of a Perennial Bone of Contention | Read More
A comprehensive analysis of cytopenias and bone marrow morphology in patients with a history of bariatric and metabolic surgery | Read More
Aerosolization risk during endoscopic transnasal surgery: a prospective qualitative and quantitative microscopic analysis of particles spreading in the operating room | Read More
Oxidative Stress Is Associated with Telomere Interaction Impairment and Chromatin Condensation Defects in Spermatozoa of Infertile Males | Read More
Method to diagnose malignant melanoma in the domestic dog | Read More
Complex three-way Philadelphia translocation t(6;9;22) (p23;q34;q11.2) along with unusual t(1;4): A chronic myeloid leukemia case report | Read More
Mutant genetically engineered mouse models of human cancers | Read More
Near-tetraploid cancer cells show chromosome instability triggered by replication stress and exhibit enhanced invasiveness | Read More
Assessment of sperm nuclear quality after in vitro maturation of fresh or frozen/thawed mouse pre-pubertal testes | Read More
Isolation of Circulating Plasma Cells in Multiple Myeloma Using CD138 Antibody-Based Capture in a Microfluidic Device| Read More
A case of Philadelphia chromosome positive acute lymphoblastic leukemia with partial trisomy of chromosome 1q involving chromosome 13 as the acceptor − a novel cytogenetic finding| Read More
In Situ Hybridization in Clinical Biomarker Development | Read More
FGFR3 Preferentially Colocalizes with IGH in the Interphase Nucleus of Multiple Myeloma Patient
B-Cells When FGFR3 Is Located Outside of CT4 | Read More
MLL: The Gene and Its Translocation Partners. 2 Cases with a t(11;17) Involving MLL and Mimicking the Variant t(11;17) RARA Translocation |Read More
Testicular versus ejaculated spermatozoa in ICSI cycles of normozoospermic men with high sperm DNA fragmentation and previous ART failures |Read More
A microfluidics approach for the isolation of nucleated red blood cells (NRBCs) from the peripheral blood of pregnant Women | Read More
An Overview on Prenatal Screening for Chromosomal Aberrations |Read More
Canine urothelial carcinoma: genomically aberrant and comparatively relevant |Read More
Comparative cytogenetic characterization of primary canine melanocytic lesions using array CGH and fluorescence in situ hybridization | Read More
